Skip to main content
. 2024 Apr 16;35(7-8):256–268. doi: 10.1089/hum.2023.177

Figure 2.

Figure 2.

IDS activity in liver, spleen, and kidney after gene therapy. IDS enzyme activity in liver (A), spleen (B), and kidney (C). (D) Sections of liver of GFP-treated and untreated Idsy/− mice stained with anti-GFP antibody. (E) Chimerism analysis of liver measured by allele-specific qPCR on the Cd45.1 locus. Data represent means ± SEM and were analyzed by one-way ANOVA followed by Bonferroni's multiple testing correction. Enzyme activity: IDSco, IDS.IGF2co, GFP, Idsy/−, and WT n = 6; IDS.ApoE2co n = 10; IDS.RAP12x2co n = 7. Chimerism: n = 6. GFP staining: n = 3. **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001. ##p ≤ 0.01, ###p ≤ 0.001, ####p ≤ 0.0001. Asterisks represent significance versus WT; hash represent significance versus Idsy/−. Significant results are indicated by brackets. ANOVA, analysis of variance; GFP, green fluorescent protein; qPCR, quantitative polymerase chain reaction; SEM, standard error of the mean.